{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "hmdb:HMDB06564",
      "entity_text" : "glucose",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0079" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Although the EMA considers that the benefits of SGLT2i continue to outweigh the risks in the treatment in T2DM 4, we would like to alert about SGLT2 inhibitors being able to cause DKA with undetectable or low levels of urine ketone bodies and only slightly elevated blood glucose, making diagnosis problematic.",
  "reading_complete" : "2020-08-02T08:42:32Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T08:41:50Z",
  "trigger" : "levels",
  "evidence" : [ "levels of urine ketone bodies and only slightly elevated blood glucose" ],
  "pmc_id" : "5458028",
  "score" : 0
}